peter cook: relenza could be worth a$200m p/a

I have uncovered a previously unreported interview with Peter Cook:

http://tinyurl.com/qvhtyr

Selected highlights:

Peter Cook, Biota’s chief executive officer, told EP Vantage that Relenza royalties could triple in the current financial year and ultimately reach A$200m ($150m) on an annual basis

Aside from Roche and Glaxo as natural partners for CS-8958 (LANI), Mr Cook also highlighted other potential big pharma partners with the required expertise to succeed in this sector, such as Sanofi-Aventis, Novartis and AstraZeneca.


worth a read!